Is 180 Life Stock a Good Investment?
180 Life Investment Advice | ATNF |
- Examine 180 Life's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research 180 Life's leadership team and their track record. Good management can help 180 Life navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact 180 Life's business and its evolving consumer preferences.
- Compare 180 Life's performance and market position to its competitors. Analyze how 180 Life is positioned in terms of product offerings, innovation, and market share.
- Check if 180 Life pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about 180 Life's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in 180 Life Sciences stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if 180 Life Sciences is a good investment.
Sell | Buy |
Sell
Market Performance | Modest | Details | |
Volatility | Very risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine 180 Life Stock
Researching 180 Life's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company has price-to-book (P/B) ratio of 1.22. Some equities with similar Price to Book (P/B) outperform the market in the long run. 180 Life Sciences recorded earning per share (EPS) of 7.98. The entity had not issued any dividends in recent years. The firm had 1:19 split on the 28th of February 2024.
To determine if 180 Life is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding 180 Life's research are outlined below:
| 180 Life Sciences is way too risky over 90 days horizon | |
| 180 Life Sciences appears to be risky and price may revert if volatility continues | |
| 180 Life Sciences has a very high chance of going through financial distress in the upcoming years | |
| 180 Life Sciences currently holds 1.05 M in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. 180 Life Sciences has a current ratio of 0.66, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about 180 Life's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (19.94 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| 180 Life Sciences currently holds about 1.63 M in cash with (10.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04. | |
| 180 Life Sciences has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: ARMISTICE CAPITAL, LLC Acquires New Stake in 180 Life Sciences C - GuruFocus.com |
180 Life uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in 180 Life Sciences. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to 180 Life's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Earnings surprises can significantly impact 180 Life's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises 180 Life's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2022-11-10 | 2022-09-30 | 0.2 | -1.4 | -1.6 | 800 | ||
2022-05-16 | 2022-03-31 | -2.6 | 1.0 | 3.6 | 138 | ||
2022-03-31 | 2021-12-31 | -2.6 | 1.0 | 3.6 | 138 | ||
2022-08-09 | 2022-06-30 | -2.6 | 1.8 | 4.4 | 169 | ||
2023-03-31 | 2022-12-31 | -0.11 | -10.8907 | -10.7807 | 9800 | ||
2024-03-25 | 2023-12-31 | 3.8 | -26.6 | -30.4 | 800 |
Know 180 Life's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as 180 Life is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading 180 Life Sciences backward and forwards among themselves. 180 Life's institutional investor refers to the entity that pools money to purchase 180 Life's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Ubs Group Ag | 2024-09-30 | 6.8 K | Citadel Advisors Llc | 2024-06-30 | 0.0 | Tower Research Capital Llc | 2024-09-30 | 2.3 K | Blackrock Inc | 2024-06-30 | 772 | Bank Of America Corp | 2024-06-30 | 12.0 | Royal Bank Of Canada | 2024-06-30 | 11.0 | Semmax Financial Advisors Inc. | 2024-09-30 | 2.0 | Qube Research & Technologies | 2024-09-30 | 0.0 | Wells Fargo & Co | 2024-06-30 | 0.0 | Jpmorgan Chase & Co | 2024-09-30 | 0.0 | Ifp Advisors, Llc | 2024-06-30 | 0.0 |
180 Life's market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.71 M.Market Cap |
|
180 Life's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (5.48) | (5.75) | |
| Return On Capital Employed | (68.46) | (65.04) | |
| Return On Assets | (3.79) | (3.98) | |
| Return On Equity | 156.07 | 163.87 |
Determining 180 Life's profitability involves analyzing its financial statements and using various financial metrics to determine if 180 Life is a good buy. For example, gross profit margin measures 180 Life's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of 180 Life's profitability and make more informed investment decisions.
Evaluate 180 Life's management efficiency
180 Life Sciences has return on total asset (ROA) of (0.635) % which means that it has lost $0.635 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.9858) %, meaning that it created substantial loss on money invested by shareholders. 180 Life's management efficiency ratios could be used to measure how well 180 Life manages its routine affairs as well as how well it operates its assets and liabilities. The 180 Life's current Return On Equity is estimated to increase to 163.87, while Return On Tangible Assets are projected to decrease to (5.75). At this time, 180 Life's Net Tangible Assets are most likely to increase significantly in the upcoming years. The 180 Life's current Debt To Assets is estimated to increase to 0.21, while Non Current Assets Total are projected to decrease to roughly 1.5 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (0.34) | (0.32) | |
| Tangible Book Value Per Share | (4.61) | (4.38) | |
| Enterprise Value Over EBITDA | (0.03) | (0.03) | |
| Price Book Value Ratio | (12.05) | (11.44) | |
| Enterprise Value Multiple | (0.03) | (0.03) | |
| Price Fair Value | (12.05) | (11.44) | |
| Enterprise Value | 709.6 K | 674.1 K |
Leadership effectiveness at 180 Life Sciences is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Beta 0.247 |
Basic technical analysis of 180 Stock
As of the 4th of December, 180 Life owns the Coefficient Of Variation of 1161.03, market risk adjusted performance of 0.5689, and Standard Deviation of 41.37. 180 Life Sciences technical analysis gives you the methodology to make use of past data patterns to determine a pattern that approximates the direction of the entity's future prices. Please confirm 180 Life Sciences information ratio, and the relationship between the downside deviation and value at risk to decide if 180 Life Sciences is priced fairly, providing market reflects its prevailing price of 2.3 per share. Please also double-check 180 Life total risk alpha, which is currently at (2.05) to validate the company can sustain itself sooner or later.180 Life's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific 180 Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on 180 Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases 180 Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
180 Life's Outstanding Corporate Bonds
180 Life issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. 180 Life Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most 180 bonds can be classified according to their maturity, which is the date when 180 Life Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| US68233JBV52 Corp BondUS68233JBV52 | View | |
| US68233JBU79 Corp BondUS68233JBU79 | View | |
| US68233JBR41 Corp BondUS68233JBR41 | View | |
| US68233JBP84 Corp BondUS68233JBP84 | View | |
| ONCOR ELEC DELIVERY Corp BondUS68233JBG85 | View |
Understand 180 Life's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing 180 Life's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0755 | |||
| Market Risk Adjusted Performance | 0.5689 | |||
| Mean Deviation | 13.02 | |||
| Semi Deviation | 7.28 | |||
| Downside Deviation | 8.48 | |||
| Coefficient Of Variation | 1161.03 | |||
| Standard Deviation | 41.37 | |||
| Variance | 1711.66 | |||
| Information Ratio | 0.0834 | |||
| Jensen Alpha | 2.9 | |||
| Total Risk Alpha | (2.05) | |||
| Sortino Ratio | 0.4068 | |||
| Treynor Ratio | 0.5589 | |||
| Maximum Drawdown | 358.73 | |||
| Value At Risk | (11.29) | |||
| Potential Upside | 16.1 | |||
| Downside Variance | 71.92 | |||
| Semi Variance | 52.99 | |||
| Expected Short fall | (24.26) | |||
| Skewness | 7.48 | |||
| Kurtosis | 58.87 |
| Risk Adjusted Performance | 0.0755 | |||
| Market Risk Adjusted Performance | 0.5689 | |||
| Mean Deviation | 13.02 | |||
| Semi Deviation | 7.28 | |||
| Downside Deviation | 8.48 | |||
| Coefficient Of Variation | 1161.03 | |||
| Standard Deviation | 41.37 | |||
| Variance | 1711.66 | |||
| Information Ratio | 0.0834 | |||
| Jensen Alpha | 2.9 | |||
| Total Risk Alpha | (2.05) | |||
| Sortino Ratio | 0.4068 | |||
| Treynor Ratio | 0.5589 | |||
| Maximum Drawdown | 358.73 | |||
| Value At Risk | (11.29) | |||
| Potential Upside | 16.1 | |||
| Downside Variance | 71.92 | |||
| Semi Variance | 52.99 | |||
| Expected Short fall | (24.26) | |||
| Skewness | 7.48 | |||
| Kurtosis | 58.87 |
Consider 180 Life's intraday indicators
180 Life intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of 180 Life stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
180 Life Corporate Filings
S1 | 15th of November 2024 Report filed by companies planning on going public to register their securities with the U.S. Securities and Exchange Commission (SEC) | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
| 12th of November 2024 Other Reports | ViewVerify | |
8K | 31st of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
180 Stock media impact
Far too much social signal, news, headlines, and media speculation about 180 Life that are available to investors today. That information is available publicly through 180 media outlets and privately through word of mouth or via 180 internal channels. However, regardless of the origin, that massive amount of 180 data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of 180 Life news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of 180 Life relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to 180 Life's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive 180 Life alpha.
180 Life Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards 180 Life can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
180 Life Corporate Executives
Elected by the shareholders, the 180 Life's board of directors comprises two types of representatives: 180 Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of 180. The board's role is to monitor 180 Life's management team and ensure that shareholders' interests are well served. 180 Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, 180 Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
Already Invested in 180 Life Sciences?
The danger of trading 180 Life Sciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of 180 Life is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than 180 Life. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile 180 Life Sciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether 180 Life Sciences is a strong investment it is important to analyze 180 Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact 180 Life's future performance. For an informed investment choice regarding 180 Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in 180 Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 180 Life. If investors know 180 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 180 Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 7.98 | Return On Assets (0.64) | Return On Equity (3.99) |
The market value of 180 Life Sciences is measured differently than its book value, which is the value of 180 that is recorded on the company's balance sheet. Investors also form their own opinion of 180 Life's value that differs from its market value or its book value, called intrinsic value, which is 180 Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 180 Life's market value can be influenced by many factors that don't directly affect 180 Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between 180 Life's value and its price, as these two are different measures arrived at by various means. Investors typically determine if 180 Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 180 Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.